Transcatheter edge-to-edge repair for primary mitral regurgitation (M-TEER) can be safely performed at centers with a low volume of surgical mitral valve repair, but new data suggest that hospitals ...
BOSTON, MA—Is the existing evidence strong enough to perform transcatheter edge-to-edge repair (TEER) in patients with heart failure (HF) and moderate functional mitral regurgitation (FMR)? That ...
NEW YORK CITY -- Newer technology strengthened the case for single-shot transcatheter edge-to-edge repair (TEER) for concomitant mitral regurgitation (MR) and tricuspid regurgitation (TR), according ...
Please provide your email address to receive an email when new articles are posted on . At 1 year, a transcatheter edge-to-edge repair device reduced mitral regurgitation to mild or less in 92.6% of ...
Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to severe ...
London, United Kingdom – 31 August 2024: Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalisations with improved health status in ...
SAN FRANCISCO -- The Pascal device remained noninferior to MitraClip for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation (DMR) in full results from ...
LONDON — Opinions about the relative value of interventions to control mitral regurgitation secondary to heart failure might be altered by two large randomized trials. The RESHAPE-HF2 trial showed ...
Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results